Listed pharmaceutical firms to cut dividend payouts on uncertainties

Korea’ listed drug firms are likely to sharply reduce their cash dividends paid out to their shareholders this year as the government’s forced price cuts for drugs and growing economic uncertainties have led them to secure capital amid a dim earnings outlook, market source said.

Given that dividend payments to shareholders tend to spike at year-end, market watchers said drug companies will p...